Live from the NIH registry
Studies recruiting near McAllen right now
Top 25 of 137 recruiting studies, sorted by proximity — each links to its official registry page
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Great Lakes Research Institute — Pharr, Texas (4.4 mi)
· Sponsor: Regeneron Pharmaceuticals
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
HCA Research Institute — McAllen, Texas (1.8 mi)
· Sponsor: Novo Nordisk A/S
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Cervical Cancer
Phase 4
Interventional 100 participants sought
Texas Oncology - Central South — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Edinburg, Texas (7.4 mi)
· Sponsor: Hoffmann-La Roche
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Pharr, Texas (4.4 mi)
· Sponsor: Akero Therapeutics, Inc
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
Ventricular Ejection Fraction, LVF
N/A
Observational 2,000 participants sought
South Heart Clinic — Weslaco, Texas (16.5 mi)
· Sponsor: Peerbridge Health, Inc
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — McAllen, Texas (1.8 mi)
· Sponsor: AstraZeneca
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
Gamma Medical Research — McAllen, Texas (1.8 mi)
· Sponsor: R1 Therapeutics
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Registry Study to Assess Photobiomodulation in Dry Age-Related Macular Degeneration (GLOBALIGHT)
Dry Age-related Macular Degeneration
N/A
Observational 500 participants sought
Valley Retina Institute — McAllen, Texas (1.8 mi)
· Sponsor: LumiThera, Inc.
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Overweight, Obesity
Phase 2
Interventional 400 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: Eli Lilly and Company
ProACT Post-Approval Study
Stress Urinary Incontinence
N/A
Interventional 145 participants sought
DHR Health Institute for Research and Development — McAllen, Texas (1.8 mi)
· Sponsor: Uromedica
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Biopharma Informatic, LLC — McAllen, Texas (1.8 mi)
· Sponsor: Eli Lilly and Company
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Metastatic Non-small Cell Lung Cancer
Phase 3
Interventional 734 participants sought
DHR Health Oncology Institute — Edinburg, Texas (7.4 mi)
· Sponsor: NovoCure GmbH
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults
Venous Thromboembolism (VTE)
Phase 3
Interventional 2,000 participants sought
Futuro Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Migraine
Phase 3
Interventional 640 participants sought
DCT-McAllen Primary Care Research, LLC dba Discovery Clinical Trials — McAllen, Texas (1.8 mi)
· Sponsor: Pfizer
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy
Phase 2
Interventional 240 participants sought
Central Recruiting Site — McAllen, Texas (1.8 mi)
· Sponsor: Dogwood Therapeutics Inc.
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Cushing Syndrome
Phase 2
Interventional 12 participants sought
Texas Valley Clinical Research — Weslaco, Texas (16.5 mi)
· Sponsor: RECORDATI GROUP
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — McAllen, Texas (1.8 mi)
· Sponsor: Akero Therapeutics, Inc
An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Pain
Phase 3
Interventional 160 participants sought
Adneuris Site 001104 — McAllen, Texas (1.8 mi)
· Sponsor: Adneuris Therapeutics, Inc.
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
STCC at DHR Health Institute for Research and Development — Edinburg, Texas (7.4 mi)
· Sponsor: SWOG Cancer Research Network
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Phase 3
Interventional 698 participants sought
A & A Research Consultants, LLC — McAllen, Texas (1.8 mi)
· Sponsor: United Therapeutics
A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age
Influenza, Human
Phase 3
Interventional 54,000 participants sought
GSK Investigational Site — Edinburg, Texas (7.4 mi)
· Sponsor: GlaxoSmithKline
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Valley Retina Institute — McAllen, Texas (1.8 mi)
· Sponsor: Astellas Pharma Global Development, Inc.